REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,970
-10 (-0.09%)
At close: Jun 5, 2025, 3:30 PM KST

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 201.20 billion as of June 6, 2025. Its market cap has decreased by -22.69% in one year.

Market Cap
201.20B
Enterprise Value
398.07B
Revenue
148.04B
Ranking
n/a
PE Ratio
49.79
Stock Price
10,970.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 201.20B, an increase of 22.27%. That is a compound annual growth rate of 1.35%.

History

DateMarket Cap% Change
Jun 5, 2025201.20B-14.56%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 72.53T
Celltrion 34.68T
ALTEOGEN 19.69T
Yuhan 7,778.15B
SK Biopharmaceuticals 7,079.52B
HLB Co., Ltd. 6,860.00B
PharmaResearch 4,976.64B
LigaChem Biosciences 3,893.48B
Market Cap Rankings